-
UNDERSTANDING HYPERTENSION IN YOUNG ADULTS: DIAGNOSIS TIMING, TIME WITHIN TARGET RANGE, AND BLOOD PRESSURE TRAJECTORIES
Mar 18, 2026, 21:38 PM -
UNCOVERING PATIENT AND CAREGIVER VOICES IN METASTATIC PROSTATE CANCER: A US SOCIAL MEDIA STUDY
Mar 18, 2026, 21:38 PM -
COMPARATIVE PHARMACOECONOMIC ASSESSMENT OF CDK4/6 INHIBITORS IN A LARGE BRAZILIAN PRIVATE PAYER
Mar 18, 2026, 21:38 PM -
REAL-WORLD DEL(17P), TP53, AND IGHV BASELINE TESTING PATTERNS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITHIN A LARGE NETWORK OF US COMMUNITY ONCOLOGY PRACTICES
Mar 18, 2026, 21:38 PM -
UNCERTAINTY PROBABILITY THRESHOLDS AND INSUFFICIENT ITERATIONS OF PROBABILISTIC SENSITIVITY ANALYSIS IN ECONOMIC EVALUATION
Mar 18, 2026, 21:38 PM -
IS SUICIDAL IDEATION RISK ASSOCIATED WITH PHARMACOTHERAPY IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)? A REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
ASSESSING THE REPRESENTATIVENESS OF SURVEY-ELIGIBLE INDIVIDUALS IDENTIFIED FROM A LARGE US NATIONAL CLAIMS DATABASE
Mar 18, 2026, 21:38 PM -
BEYOND COST AND QALYS: INTEGRATING THE APP SCORE TO IMPROVE COST-EFFECTIVENESS ANALYSIS OF DIGITAL HEALTH TECHNOLOGIES
Mar 18, 2026, 21:38 PM -
A SURVEY OF HEOR LEADERS IN PHARMA ON THE CHANGING US POLICY LANDSCAPE
Mar 18, 2026, 21:38 PM -
EXAMINING THE EQUITY OF DISTRIBUTION OF GLP-1 PRESCRIPTIONS IN A LARGE URBAN PRIMARY CARE SYSTEM
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF INTRODUCING PCV20 IN COLOMBIAN PEDIATRIC POPULATION: A COST UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE
Mar 18, 2026, 21:38 PM -
EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY
Mar 18, 2026, 21:38 PM -
BRIDGING THE GAP: DEMOGRAPHIC REWEIGHTING OF REAL-WORLD SURVIVAL DATA VERSUS RCTS IN ACUTE MYELOID LEUKEMIA
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC LITERATURE REVIEW ON FINANCIAL BURDEN, FINANCIAL TOXICITY, OUTCOMES, POTENTIAL INTERVENTIONS, AND POLICIES ASSOCIATED WITH OUT-OF-POCKET MEDICATION AND HEALTHCARE EXPENSES AMONG OLDER PATIENTS IN THE US
Mar 18, 2026, 21:38 PM -
FROM MORTALITY TO MONEY: YEARS OF LIFE LOST AND THE ECONOMIC BURDEN OF CYSTIC FIBROSIS IN COLOMBIA (2005-2023)
Mar 18, 2026, 21:38 PM -
TRENDS IN PREECLAMPSIA PREVALENCE AND COMORBIDITY BURDEN AMONG PREGNANT WOMEN USING U.S. ADMINISTRATIVE CLAIMS DATA
Mar 18, 2026, 21:38 PM -
EVALUATING THE COST-EFFECTIVENESS OF PHARMACOGENETIC TESTING VIA THE MANTARA® PGX DNA TEST: INSIGHTS FROM NHS HEALTH CHECK INTEGRATION AND UK-BASED ECONOMIC MODELLING
Mar 18, 2026, 21:38 PM -
MIGRAINE BURDEN OF ILLNESS AMONG A COMMERCIALLY INSURED US POPULATION (IFORM-I)
Mar 18, 2026, 21:38 PM -
BUDGET IMPACT ANALYSIS OF EXAGAMGLOGENE AUTOTEMCEL FOR PATIENTS WITH SICKLE CELL DISEASE AND RECURRENT VASO-OCCLUSIVE EVENTS IN THE UNITED STATES
Mar 18, 2026, 21:38 PM
